Cargando…

Optimizing Mycophenolic Acid Exposure in Kidney Transplant Recipients: Time for Target Concentration Intervention

The immunosuppressive agent mycophenolate is used extensively in kidney transplantation, yet dosing strategy applied varies markedly from fixed dosing (“one-dose-fits-all”), to mycophenolic acid (MPA) trough concentration monitoring, to dose optimization to an MPA exposure target (as area under the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metz, David K., Holford, Nick, Kausman, Joshua Y., Walker, Amanda, Cranswick, Noel, Staatz, Christine E., Barraclough, Katherine A., Ierino, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756255/ https://www.ncbi.nlm.nih.gov/pubmed/31584924 http://dx.doi.org/10.1097/TP.0000000000002762

Ejemplares similares

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
por: Barraclough, Katherine A., et al.
Publicado: (2011)

The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients
por: AbdElhalim, Mohamed S., et al.
Publicado: (2020)

Nonlinear relationship between enteric-coated mycophenolate sodium dose and mycophenolic acid exposure in Han kidney transplantation recipients
por: Zhang, Jun, et al.
Publicado: (2017)

Mycophenolic Acid Trough Concentration and Dose Are Associated with Hematologic Abnormalities but Not Rejection in Kidney Transplant Recipients
por: Jung, Hee-Yeon, et al.
Publicado: (2020)

Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
por: Størset, Elisabet, et al.
Publicado: (2014)

Intra-individual variability of mycophenolic acid concentration according to renal function in liver transplant recipients receiving mycophenolate monotherapy
por: Hwang, Shin, et al.
Publicado: (2017)

Plasmapheresis Reduces Mycophenolic Acid Concentration: A Study of Full AUC(0–12) in Kidney Transplant Recipients
por: Piyasiridej, Sudarat, et al.
Publicado: (2019)

Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
por: Gardiner, Kyle M., et al.
Publicado: (2018)

Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients
por: Sunder-Plassmann, Gere, et al.
Publicado: (2012)

Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients
por: Zhang, Jun, et al.
Publicado: (2018)

Serum Selenium, Iron, Zinc, and Copper Concentrations in Renal Transplant Recipients Treated with Mycophenolate Mofetil
por: Wilk, Aleksandra, et al.
Publicado: (2020)

Transplant Prognosis in Kidney Transplant Recipients with Diabetes under Mycophenolic Acid-Focused Therapeutic Drug Monitoring
por: Nakamura, Eisuke, et al.
Publicado: (2021)

Limited Sampling Strategy for Estimation of Mycophenolic Acid Exposure in Adult Chinese Heart Transplant Recipients
por: Xiang, Hongping, et al.
Publicado: (2021)

Estimation of Mycophenolic Acid Exposure in Heart Transplant Recipients by Population Pharmacokinetic and Limited Sampling Strategies
por: Wang, Xipei, et al.
Publicado: (2021)

Pharmacokinetics of mycophenolic acid and its phenyl glucuronide metabolite in kidney transplant recipients with renal impairment
por: Kamińska, Jolanta, et al.
Publicado: (2012)

Mycophenolate Monotherapy in HLA-Matched Kidney Transplant Recipients: A Case Series of 20 Patients
por: Hennes, Anthony J., et al.
Publicado: (2020)

Mycophenolic acid AUC in Thai kidney transplant recipients receiving low dose mycophenolate and its association with UGT2B7 polymorphisms
por: Pithukpakorn, Manop, et al.
Publicado: (2014)

Effect of Mycophenolate Mofetil on Plasma Bioelements in Renal Transplant Recipients
por: Kamińska, Jolanta, et al.
Publicado: (2011)

Effect of Protein Binding on Exposure of Unbound and Total Mycophenolic Acid: A Population Pharmacokinetic Analysis in Chinese Adult Kidney Transplant Recipients
por: Sheng, Changcheng, et al.
Publicado: (2020)

Pharmacokinetic and Pharmacodynamic Considerations in Relation to Calcineurin Usage in Elderly Kidney Transplant Recipients
por: Cossart, Amelia R., et al.
Publicado: (2021)

Comparison of PETINIA and LC-MS/MS for determining plasma mycophenolic acid concentrations in Japanese lung transplant recipients
por: Kikuchi, Masafumi, et al.
Publicado: (2018)

Celiac-like Enteropathy Associated With Mycophenolate Sodium in Renal Transplant Recipients
por: Filiopoulos, Vassilis, et al.
Publicado: (2018)

Life-threatening adenovirus infection in a kidney transplant recipient
por: Barraclough, Katherine, et al.
Publicado: (2009)

Withdrawing mycophenolate mofetil in treating a young kidney transplant recipient with COVID-19: A case report
por: Chen, Dong, et al.
Publicado: (2020)

Kidney transplant recipient perspectives on telehealth during the COVID‐19 pandemic
por: Huuskes, Brooke M, et al.
Publicado: (2021)

Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities
por: Tornatore, Kathleen M., et al.
Publicado: (2023)

Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients
por: Chiang, Heng-Yi, et al.
Publicado: (2023)

The Burden of Gastrointestinal Complaints in Kidney Transplant Recipients Using Tacrolimus With and Without Mycophenolate Mofetil: A Randomized Controlled Study
por: Fatly, Zainab Al, et al.
Publicado: (2022)

Exploring Transplant Medication-Taking Behaviours in Older Adult Kidney Transplant Recipients: A Qualitative Study of Semi-Structured Interviews
por: Cossart, Amelia R., et al.
Publicado: (2022)

Immune response to third SARS‐CoV‐2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction
por: Kantauskaite, Marta, et al.
Publicado: (2022)

A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Severe Mycophenolate Intoxication in a Solid Organ Transplant Recipient—No Intervention Actually Needed
por: Åsberg, Anders, et al.
Publicado: (2020)

Orthotopic Heart Transplant Recipient with Enteric-coated Mycophenolate Sodium (Myfortic) Induced Colitis
por: Morris, Craig C., et al.
Publicado: (2020)

Mycophenolate mofetil increases the risk of diarrhea in allogeneic hematopoietic stem cell transplantation recipients
por: Lin, Liangmo, et al.
Publicado: (2023)

Early Post-Transplant Leptin Concentration Changes in Kidney Transplant Recipients
por: Sukackiene, Diana, et al.
Publicado: (2021)

Exposure to Mycophenolate and Fatherhood
por: Midtvedt, Karsten, et al.
Publicado: (2017)

Long-term results of a calcineurin inhibitor-free immunosuppression based on Thymoglobulin® and mycophenolate mofetil in elderly kidney transplant recipients
por: Kamar, Nassim, et al.
Publicado: (2008)

Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients
por: Kantauskaite, Marta, et al.
Publicado: (2022)

COVID-19 Vaccination Response in Kidney Transplant Recipients With and Without Mycophenolate Mofetil: Follow-up of a Randomized Controlled Trial
por: Al Fatly, Zainab, et al.
Publicado: (2022)

Mycophenolate Induced Colitis: One-year Post-kidney Transplantation
por: Al Saadi, Waleed, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_214lkhf6n28q17tnlipepmdm5c